David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VMW
2026
CALL
DELISTED
VMware, Inc
VMW
| $1.57M | ﹤0.01% |
30,000
| – | – |
|
2027
CAE Inc
CAE
$8.08B
| $1.57M | ﹤0.01% |
135,469
+98,200
| +263% | +$1.06M |
|
|
MCRN
2028
DELISTED
Milacron Holdings Corp.
MCRN
| $1.56M | ﹤0.01% |
94,663
-9,422
| -9% | -$132K |
|
|
HTO
2029
H2O America
HTO
$2.66B
| $1.56M | ﹤0.01% |
42,908
+17,567
| +69% | +$591K |
|
2030
RenaissanceRe
RNR
$13.9B
| $1.56M | ﹤0.01% |
13,007
-209,462
| -94% | -$23.8M |
|
2031
Insmed
INSM
$26.9B
| $1.56M | ﹤0.01% |
122,819
-17,866
| -13% | -$235K |
|
2032
CALL
BHP
BHP
$247B
| $1.55M | ﹤0.01% |
67,260
-100,442
| -60% | -$2.13M |
|
2033
TJX Companies
TJX
$152B
| $1.55M | ﹤0.01% |
39,646
-652,074
| -94% | -$23.7M |
|
2034
CALL
Autodesk
ADSK
$53.2B
| $1.55M | ﹤0.01% |
26,600
-34,300
| -56% | -$1.79M |
|
2035
Roper Technologies
ROP
$40.8B
| $1.55M | ﹤0.01% |
8,486
+3,871
| +84% | +$667K |
|
2036
Brixmor Property Group
BRX
$9.08B
| $1.55M | ﹤0.01% |
60,503
-76,776
| -56% | -$1.89M |
|
2037
PUT
Broadcom
AVGO
$1.69T
| $1.54M | ﹤0.01% |
100,000
-562,000
| -85% | -$7.6M |
|
2038
Tractor Supply
TSCO
$18.3B
| $1.54M | ﹤0.01% |
85,400
-317,670
| -79% | -$5.44M |
|
2039
Citizens Financial Group
CFG
$29.7B
| $1.54M | ﹤0.01% |
73,583
-564,817
| -88% | -$12M |
|
|
BID
2040
PUT
DELISTED
Sotheby's
BID
| $1.54M | ﹤0.01% |
57,600
+29,900
| +108% | +$718K |
|
2041
CALL
Herbalife
HLF
$1.33B
| $1.54M | ﹤0.01% |
50,000
-660,000
| -93% | -$17M |
|
|
AUD
2042
DELISTED
Audacy, Inc.
AUD
| $1.54M | ﹤0.01% |
145,462
+15,637
| +12% | +$166K |
|
|
VVUS
2043
DELISTED
Vivus Inc
VVUS
| $1.54M | ﹤0.01% |
109,900
-10,680
| -9% | -$114K |
|
2044
StoneX
SNEX
$8.31B
| $1.54M | ﹤0.01% |
291,104
-244,235
| -46% | -$1.32M |
|
|
CHMT
2045
DELISTED
Chemtura Corporation
CHMT
| $1.54M | ﹤0.01% |
58,213
-98,065
| -63% | -$2.51M |
|
|
CBR
2046
DELISTED
CIBER Inc.
CBR
| $1.53M | ﹤0.01% |
727,505
+15,167
| +2% | +$38.7K |
|
2047
CRA International
CRAI
$1.08B
| $1.53M | ﹤0.01% |
78,086
+14,222
| +22% | +$268K |
|
|
ANH
2048
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $1.53M | ﹤0.01% |
328,592
+192,843
| +142% | +$862K |
|
2049
PUT
Kroger
KR
$35.9B
| $1.53M | ﹤0.01% |
40,000
-888,000
| -96% | -$34.3M |
|
|
TBHC
2050
DELISTED
The Brand House Collective
TBHC
| $1.53M | ﹤0.01% |
+87,242
| New | +$1.22M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.